Follow the オンコセラピー・サイエンス株式会社 share price and the full directors' dealings record of the company, a listed equity based in Japan. Shares trade on JP JP, under the authority of EDINET (Japan FSA). Operating in the Health Care sector, オンコセラピー・サイエンス株式会社 has recorded 58 insider filings. Market capitalisation: €8bn. The latest transaction was filed on 15 June 2026 (Holding update). Among the most active insiders: Long Corridor Asset Management Limited. The full history is free.
58
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
19Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 27,537 of 28,064 companies
9.4
score / 100
Value
15
Quality
4
FCF yld-12%
Earn yld-11%
EV/EBITDA·
ROE-63%
Gross mgn1.7%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
OncoTherapy Science Inc. is a company focused on developing innovative therapies for cancer treatment. It specializes in research and commercialization of therapeutic solutions in the healthcare and pharmaceutical sector.